规格: | 98% |
分子量: | 363.5 |
包装 | 价格(元) |
50ug | 电议 |
100ug | 电议 |
Background:
11β-Prostaglandin F2α-d9(11β-PGF2α-d9) is intended for use as an internal standard for the quantification of 11β-PGF2αby GC- or LC-MS. 11β-PGF2αis the primary metabolite of PGD2.1It is formed from PGD2viathe NADPH-dependent aldo-keto reductase PGF synthase in the liver or lung.211β-PGF2αinduces contraction of isolated cat iris sphincter, which endogenously expresses high levels of PGF2α(FP) receptors, with an EC50value of 0.045 µM.1It also induces contraction of isolated human bronchial smooth muscle when used at concentrations ranging from 0.1 to 30 µM.311β-PGF2α(0.1 and 1 µM) induces phosphorylation of ERK and CREB, as well as increases the viability of MCF-7 breast cancer cells stably expressing the FP receptor when used at concentrations of 0.1 and 1 µM.4
1.Giles, H., Bolofo, M.L., Lydford, S.J., et al.A comparative study of the prostanoid receptor profile of 9α 11 β-prostaglandin F2 and prostaglandin D2Br. J. Pharmacol.104(2)541-549(1991) 2.Watanabe, K.Prostaglandin F synthaseProstaglandins Other Lipid Mediat.68-69401-407(2002) 3.Coleman, R.A., and Sheldrick, R.L.G.Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP-receptorsBr. J. Pharmacol.96(3)688-692(1989) 4.Yoda, T., Kikuchi, K., Miki, Y., et al.11β-Prostaglandin F2α, a bioactive metabolite catalyzed by AKR1C3, stimulates prostaglandin F receptor and induces slug expression in breast cancerMol. Cell. Endocrinol.413236-247(2015)